Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study

Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) due to lack of pharmacodynamic data for pimobendan i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Vet Sci
Autors principals: Oldach, Maureen S., Ueda, Yu, Ontiveros, Eric S., Fousse, Samantha L., Harris, Samantha P., Stern, Joshua A.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Veterinary Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6369151/
https://ncbi.nlm.nih.gov/pubmed/30778391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2019.00015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars